PCI launches innovative product line: phosphonic acids, used in a wide variety of commercial applications
PCI Synthesis (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufacturers new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and complex specialty chemicals, today announced the general availability of phosphonic acids, widely used by researchers and developers of nano-particle technology applications around the world, and the launch of its new web page phosphonicacid.com.
Ed Price, president of PCI, said, “More than 200 of our worldwide customers and academic partners use PCI’s phosphonic acids today. Innovation and quality have long been hallmarks of PCI, and our phosphonic product line is the latest example.”
PCI’s growing industry reputation is reflected in its latest industry accolades: PCI just won four categories of the 2013 Life Science Leader CMO Leadership Awards for quality, innovation, productivity and reliability.
Phosphonic acids have wide commercial use as surfactants for the manufacture of a host of different nano-particle technologies, used in the electronics and alternative energy industries. Phosphonic acids also have unique properties as chelating agents that can be utilized in certain specific microelectronic applications as well. For more than 10 years PCI’s phosphonic acids have been used widely by nanotechnology manufacturers, governments and research institutions around the world.
“We manufacture eight phosphonic acids today, available in small quantities such as 10g all the way up to several metric tons,” concluded Price, “We have developed processes that produce these materials in very high purity and low metals content. We have also developed sophisticated analytical tools that allow us to analyze these materials.”
For more information about PCI’s phosphonic acids product line, please visit: phosphonicacid.com.
About PCI Synthesis
PCI Synthesis is a 13-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products. A contract manufacturing organization (CMO), PCI provides emerging and mid-sized pharmaceutical companies access to the expertise needed to develop and manufacture complex small molecules and APIs used in generic pharmaceuticals. To learn more about PCI Synthesis, its proprietary NCE development activities and process R&D capabilities please visit www.pcisynthesis.com.
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.